Cormedix (NASDAQ:CRMD) just reported results for the second quarter of 2024.
- Cormedix reported earnings per share of -25 cents. This met the analyst estimate for EPS of -25 cents.
- The company reported revenue of $806,119.
- This was 51.73% worse than the analyst estimate for revenue of $1.67 million.